CVE-2024-42178: Hcltech Dryice Myxalytics

High severity, CVSS 7.5. EPSS: 0.2% chance of exploitation in the next 30 days.

HCL MyXalytics is affected by a failure to restrict URL access vulnerability. Unauthenticated users might gain unauthorized access to potentially confidential information, creating a risk of misuse, manipulation, or unauthorized distribution.

Affected products

• Hcltech Dryice Myxalytics: version 6.3 only

Published 2025-04-17. Last modified 2026-06-17.